U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Device Advice: Comprehensive Regulatory Assistance
  4. Guidance Documents (Medical Devices and Radiation-Emitting Products)
  5. Tryptase Test System as an Aid in the Diagnosis of Systemic Mastocytosis - Class II Special Controls Guideline
  1. Guidance Documents (Medical Devices and Radiation-Emitting Products)

Tryptase Test System as an Aid in the Diagnosis of Systemic Mastocytosis - Class II Special Controls Guideline

Read the Special Controls Document

Issue Date: 09/18/2014

Issued By: Office of Medical Products and Tobacco, Center for Devices and Radiological Health, Office of In Vitro Diagnostics and Radiological Health

This document was developed as a special controls guideline to support the classification of a tryptase test system into class II (special controls). A tryptase test system is a device that aids in the diagnosis of systemic mastocytosis. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of patients with a suspicion of systemic mastocytosis in conjunction with other clinical and laboratory findings.

Back to Top